Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · IEX Real-Time Price · USD
6.01
+0.29 (5.07%)
At close: May 9, 2024, 12:47 PM
6.18
+0.17 (2.83%)
After-hours: May 9, 2024, 6:54 PM EDT
POCI Revenue
Precision Optics Corporation had revenue of $19.22M in the twelve months ending December 31, 2023, down -5.87% year-over-year. Revenue in the quarter ending December 31, 2023 was $4.82M, a -18.05% decrease year-over-year. In the fiscal year ending June 30, 2023, Precision Optics Corporation had annual revenue of $21.04M with 34.23% growth.
Revenue (ttm)
$19.22M
Revenue Growth
-5.87%
P/S Ratio
1.92
Revenue / Employee
$228,783
Employees
84
Market Cap
36.90M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 21.04M | 5.37M | 34.23% |
Jun 30, 2022 | 15.68M | 5.00M | 46.87% |
Jun 20, 2021 | 10.67M | 751.55K | 7.57% |
Jun 30, 2020 | 9.92M | 3.12M | 45.84% |
Jun 30, 2019 | 6.80M | 2.77M | 68.50% |
Jun 30, 2018 | 4.04M | 883.50K | 28.01% |
Jun 30, 2017 | 3.15M | -762.16K | -19.46% |
Jun 30, 2016 | 3.92M | 4.64K | 0.12% |
Jun 30, 2015 | 3.91M | 260.88K | 7.15% |
Jun 30, 2014 | 3.65M | 1.13M | 44.90% |
Jun 30, 2013 | 2.52M | 367.35K | 17.07% |
Jun 30, 2012 | 2.15M | -92.74K | -4.13% |
Jun 30, 2011 | 2.25M | -849.30K | -27.45% |
Jun 30, 2010 | 3.09M | -434.07K | -12.30% |
Jun 30, 2009 | 3.53M | 626.29K | 21.58% |
Jun 30, 2008 | 2.90M | 424.75K | 17.14% |
Jun 30, 2007 | 2.48M | 327.91K | 15.25% |
Jun 30, 2006 | 2.15M | 799.75K | 59.25% |
Jun 30, 2005 | 1.35M | -122.19K | -8.30% |
Jun 30, 2004 | 1.47M | -927.21K | -38.65% |
Jun 30, 2003 | 2.40M | 624.93K | 35.22% |
Jun 30, 2002 | 1.77M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fortress Biotech | 84.51M |
CASI Pharmaceuticals | 33.88M |
Rapid Micro Biosystems | 23.10M |
ImmunoPrecise Antibodies | 17.67M |
Palatin Technologies | 7.10M |
Evogene | 5.64M |
IGC Pharma | 1.22M |
POCI News
- 1 day ago - Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024 - GlobeNewsWire
- 14 days ago - Precision Optics Announces Receipt of $1.26 Million Follow On Production Order from Large Defense Company - GlobeNewsWire
- 16 days ago - Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 - GlobeNewsWire
- 21 days ago - Precision Optics Announces Receipt of $720,000 Follow-On Production Order from Top Tier Defense/Aerospace Customer for New Optical Application - GlobeNewsWire
- 3 months ago - Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results - PRNewsWire
- 3 months ago - Precision Optics Corporation Schedules Second Quarter of Fiscal Year 2024 Conference Call for Wednesday, February 14, 2024 - PRNewsWire
- 3 months ago - Precision Optics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024 - PRNewsWire
- 5 months ago - Precision Optics Enters into Production and Technology Licensing Agreement for Single-Use Cystoscopy Robotic Surgery Program - PRNewsWire